Lynside® Immunity Prebiotic is the first patented yeast-based prebiotic. Its complex structure is degraded only by a few fundamental bacteria species not usually targeted by other prebiotics.
A dynamic in-vitro gut model study shows a long-lasting fermentation of Lynside® Immunity Prebiotic in proximal and distal colons. This scenario challenges the current prebiotic side effects, as it requires a very low daily dosage and promotes a continuing prebiotic response with low gas production. It induces both an adapted metabolic activity and a modulation of the microbiota composition, depending on the host enterotype. Lynside® Immunity Prebiotic offers untapped opportunities for personalized and adapted micronutrition to design new products dedicated to immune health.
